Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI

Professor of Medicine (Cardiology), and Population Health Science and Policy; Director of Interventional Cardiovascular Research and Clinical Trials
Icahn School of Medicine at Mount Sinai
New York, New York, United States

Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI
Dr. Roxana Mehran is an internationally renowned interventional cardiologist and clinical research expert. She built a globally-respected academic research center focused on developing randomized clinical trials and has served as principal investigator for global studies, developed risk scores for bleeding and acute kidney injury, participates regularly in developing clinical guidelines, and has authored >1300 peer-reviewed articles. She is a current member of the ACC Board of Trustees. Listed as Clarivate Analytics Most Cited Researchers, Top 1%, and Thomson Reuters list of The World’s Most Influential Scientific Minds.
She leads the Lancet Commission on Women’s Cardiovascular Disease, named Director of Women Heart and Vascular Center at Mount Sinai. In 2019, she founded Women as One, dedicated to advancing opportunities for women in medicine.

Presentation(s):

• CARDIOTUBE INTERVIEW: Is there a gender disparity in DAPT duration the Onyx substudy

  Saturday, February 25, 2023
  11:15 AM – 11:25 AM ET

  Disclosure information not submitted.

• FEATURED CLINICAL SCIENCE SESSION | SATURDAY (NON-CME)

  Saturday, February 25, 2023
  12:30 PM – 1:30 PM ET

  Disclosure(s): Abbot, abiomed, alleviant medical, amgen, am-pharma, arena, AstraZeneca, Atricure: Grant/Research Support (Ongoing); Applied Therapeutics, Elixir Medical, Stel, ControlRad (spouse): Stock-privately held company (Ongoing); Bayer, Biosensors, Biotronik, Boston Scientific, Bristol-Myers Squibb, CardiaWave, CeloNova, Chiesi: Grant/Research Support (Ongoing); Cine-Med Research, Ionis Pharmaceuticals, Novartis, Novo Nordisk, Vectura, WebMD: Consultant (Ongoing); Concept Medical, CSL Behring, Cytosorbents, Daiichi Sankyo, Element Science, Faraday, Filterlex Medical, Humacyte, Idorsia Pharmaceuticals, Janssen, Mediasphere, Medtelligence: Grant/Research Support (Ongoing); Medtronic, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Protembis, RenalPro, RM Global, Shockwave, Vivasure, Zoll: Grant/Research Support (Ongoing); Scientific Advisory Board for AMA, ACC (BOT Member, SC Member CTR Program), SCAI (Women in Innovations Committee Member), JAMA Cardiology Associate Editor; Faculty CRF: Scientific Advisory Board (Ongoing)

• Sex-Based Outcomes After PCI in Complex High Bleeding Risk Patients: 2-Year Results from the Onyx One Clear Study

  Saturday, February 25, 2023
  12:45 PM – 12:55 PM ET

  Disclosure(s): Abbot, abiomed, alleviant medical, amgen, am-pharma, arena, AstraZeneca, Atricure: Grant/Research Support (Ongoing); Applied Therapeutics, Elixir Medical, Stel, ControlRad (spouse): Stock-privately held company (Ongoing); Bayer, Biosensors, Biotronik, Boston Scientific, Bristol-Myers Squibb, CardiaWave, CeloNova, Chiesi: Grant/Research Support (Ongoing); Cine-Med Research, Ionis Pharmaceuticals, Novartis, Novo Nordisk, Vectura, WebMD: Consultant (Ongoing); Concept Medical, CSL Behring, Cytosorbents, Daiichi Sankyo, Element Science, Faraday, Filterlex Medical, Humacyte, Idorsia Pharmaceuticals, Janssen, Mediasphere, Medtelligence: Grant/Research Support (Ongoing); Medtronic, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Protembis, RenalPro, RM Global, Shockwave, Vivasure, Zoll: Grant/Research Support (Ongoing); Scientific Advisory Board for AMA, ACC (BOT Member, SC Member CTR Program), SCAI (Women in Innovations Committee Member), JAMA Cardiology Associate Editor; Faculty CRF: Scientific Advisory Board (Ongoing)

• Are Risk Scoring Systems Still Useful in Selecting ACS Patients for Angiography?

  Saturday, February 25, 2023
  2:26 PM – 2:34 PM ET

  Disclosure(s): Abbot, abiomed, alleviant medical, amgen, am-pharma, arena, AstraZeneca, Atricure: Grant/Research Support (Ongoing); Applied Therapeutics, Elixir Medical, Stel, ControlRad (spouse): Stock-privately held company (Ongoing); Bayer, Biosensors, Biotronik, Boston Scientific, Bristol-Myers Squibb, CardiaWave, CeloNova, Chiesi: Grant/Research Support (Ongoing); Cine-Med Research, Ionis Pharmaceuticals, Novartis, Novo Nordisk, Vectura, WebMD: Consultant (Ongoing); Concept Medical, CSL Behring, Cytosorbents, Daiichi Sankyo, Element Science, Faraday, Filterlex Medical, Humacyte, Idorsia Pharmaceuticals, Janssen, Mediasphere, Medtelligence: Grant/Research Support (Ongoing); Medtronic, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Protembis, RenalPro, RM Global, Shockwave, Vivasure, Zoll: Grant/Research Support (Ongoing); Scientific Advisory Board for AMA, ACC (BOT Member, SC Member CTR Program), SCAI (Women in Innovations Committee Member), JAMA Cardiology Associate Editor; Faculty CRF: Scientific Advisory Board (Ongoing)

• Panel Discussion: Contemporary Topics in STEMI and ACS

  Saturday, February 25, 2023
  2:58 PM – 3:15 PM ET

  Disclosure(s): Abbot, abiomed, alleviant medical, amgen, am-pharma, arena, AstraZeneca, Atricure: Grant/Research Support (Ongoing); Applied Therapeutics, Elixir Medical, Stel, ControlRad (spouse): Stock-privately held company (Ongoing); Bayer, Biosensors, Biotronik, Boston Scientific, Bristol-Myers Squibb, CardiaWave, CeloNova, Chiesi: Grant/Research Support (Ongoing); Cine-Med Research, Ionis Pharmaceuticals, Novartis, Novo Nordisk, Vectura, WebMD: Consultant (Ongoing); Concept Medical, CSL Behring, Cytosorbents, Daiichi Sankyo, Element Science, Faraday, Filterlex Medical, Humacyte, Idorsia Pharmaceuticals, Janssen, Mediasphere, Medtelligence: Grant/Research Support (Ongoing); Medtronic, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Protembis, RenalPro, RM Global, Shockwave, Vivasure, Zoll: Grant/Research Support (Ongoing); Scientific Advisory Board for AMA, ACC (BOT Member, SC Member CTR Program), SCAI (Women in Innovations Committee Member), JAMA Cardiology Associate Editor; Faculty CRF: Scientific Advisory Board (Ongoing)

• STEMI 2022 CONTEMPORARY TOPICS | THROMBUS MANAGEMENT AND ANTICOAGULATION

  Saturday, February 25, 2023
  3:15 PM – 4:53 PM ET

  Disclosure(s): Abbot, abiomed, alleviant medical, amgen, am-pharma, arena, AstraZeneca, Atricure: Grant/Research Support (Ongoing); Applied Therapeutics, Elixir Medical, Stel, ControlRad (spouse): Stock-privately held company (Ongoing); Bayer, Biosensors, Biotronik, Boston Scientific, Bristol-Myers Squibb, CardiaWave, CeloNova, Chiesi: Grant/Research Support (Ongoing); Cine-Med Research, Ionis Pharmaceuticals, Novartis, Novo Nordisk, Vectura, WebMD: Consultant (Ongoing); Concept Medical, CSL Behring, Cytosorbents, Daiichi Sankyo, Element Science, Faraday, Filterlex Medical, Humacyte, Idorsia Pharmaceuticals, Janssen, Mediasphere, Medtelligence: Grant/Research Support (Ongoing); Medtronic, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Protembis, RenalPro, RM Global, Shockwave, Vivasure, Zoll: Grant/Research Support (Ongoing); Scientific Advisory Board for AMA, ACC (BOT Member, SC Member CTR Program), SCAI (Women in Innovations Committee Member), JAMA Cardiology Associate Editor; Faculty CRF: Scientific Advisory Board (Ongoing)

• Panel Discussion: Thrombus Management and Anticoagulation

  Saturday, February 25, 2023
  4:35 PM – 4:53 PM ET

  Disclosure(s): Abbot, abiomed, alleviant medical, amgen, am-pharma, arena, AstraZeneca, Atricure: Grant/Research Support (Ongoing); Applied Therapeutics, Elixir Medical, Stel, ControlRad (spouse): Stock-privately held company (Ongoing); Bayer, Biosensors, Biotronik, Boston Scientific, Bristol-Myers Squibb, CardiaWave, CeloNova, Chiesi: Grant/Research Support (Ongoing); Cine-Med Research, Ionis Pharmaceuticals, Novartis, Novo Nordisk, Vectura, WebMD: Consultant (Ongoing); Concept Medical, CSL Behring, Cytosorbents, Daiichi Sankyo, Element Science, Faraday, Filterlex Medical, Humacyte, Idorsia Pharmaceuticals, Janssen, Mediasphere, Medtelligence: Grant/Research Support (Ongoing); Medtronic, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Protembis, RenalPro, RM Global, Shockwave, Vivasure, Zoll: Grant/Research Support (Ongoing); Scientific Advisory Board for AMA, ACC (BOT Member, SC Member CTR Program), SCAI (Women in Innovations Committee Member), JAMA Cardiology Associate Editor; Faculty CRF: Scientific Advisory Board (Ongoing)

• OPTIMIZATION OF ANTICOAGULATION THERAPY FOR ACS PATIENTS

  Saturday, February 25, 2023
  6:00 PM – 7:55 PM ET

  Disclosure(s): Abbot, abiomed, alleviant medical, amgen, am-pharma, arena, AstraZeneca, Atricure: Grant/Research Support (Ongoing); Applied Therapeutics, Elixir Medical, Stel, ControlRad (spouse): Stock-privately held company (Ongoing); Bayer, Biosensors, Biotronik, Boston Scientific, Bristol-Myers Squibb, CardiaWave, CeloNova, Chiesi: Grant/Research Support (Ongoing); Cine-Med Research, Ionis Pharmaceuticals, Novartis, Novo Nordisk, Vectura, WebMD: Consultant (Ongoing); Concept Medical, CSL Behring, Cytosorbents, Daiichi Sankyo, Element Science, Faraday, Filterlex Medical, Humacyte, Idorsia Pharmaceuticals, Janssen, Mediasphere, Medtelligence: Grant/Research Support (Ongoing); Medtronic, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Protembis, RenalPro, RM Global, Shockwave, Vivasure, Zoll: Grant/Research Support (Ongoing); Scientific Advisory Board for AMA, ACC (BOT Member, SC Member CTR Program), SCAI (Women in Innovations Committee Member), JAMA Cardiology Associate Editor; Faculty CRF: Scientific Advisory Board (Ongoing)

• Panel Discussion

  Saturday, February 25, 2023
  6:46 PM – 7:00 PM ET

  Disclosure(s): Abbot, abiomed, alleviant medical, amgen, am-pharma, arena, AstraZeneca, Atricure: Grant/Research Support (Ongoing); Applied Therapeutics, Elixir Medical, Stel, ControlRad (spouse): Stock-privately held company (Ongoing); Bayer, Biosensors, Biotronik, Boston Scientific, Bristol-Myers Squibb, CardiaWave, CeloNova, Chiesi: Grant/Research Support (Ongoing); Cine-Med Research, Ionis Pharmaceuticals, Novartis, Novo Nordisk, Vectura, WebMD: Consultant (Ongoing); Concept Medical, CSL Behring, Cytosorbents, Daiichi Sankyo, Element Science, Faraday, Filterlex Medical, Humacyte, Idorsia Pharmaceuticals, Janssen, Mediasphere, Medtelligence: Grant/Research Support (Ongoing); Medtronic, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Protembis, RenalPro, RM Global, Shockwave, Vivasure, Zoll: Grant/Research Support (Ongoing); Scientific Advisory Board for AMA, ACC (BOT Member, SC Member CTR Program), SCAI (Women in Innovations Committee Member), JAMA Cardiology Associate Editor; Faculty CRF: Scientific Advisory Board (Ongoing)

• Why Should we Worry and How to Treat LP(a)

  Saturday, February 25, 2023
  7:32 PM – 7:40 PM ET

  Disclosure information not submitted.

• Panel Discussion: Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy – Personalizing Treatment to Optimize Outcomes

  Saturday, February 25, 2023
  7:40 PM – 7:55 PM ET

  Disclosure(s): Abbot, abiomed, alleviant medical, amgen, am-pharma, arena, AstraZeneca, Atricure: Grant/Research Support (Ongoing); Applied Therapeutics, Elixir Medical, Stel, ControlRad (spouse): Stock-privately held company (Ongoing); Bayer, Biosensors, Biotronik, Boston Scientific, Bristol-Myers Squibb, CardiaWave, CeloNova, Chiesi: Grant/Research Support (Ongoing); Cine-Med Research, Ionis Pharmaceuticals, Novartis, Novo Nordisk, Vectura, WebMD: Consultant (Ongoing); Concept Medical, CSL Behring, Cytosorbents, Daiichi Sankyo, Element Science, Faraday, Filterlex Medical, Humacyte, Idorsia Pharmaceuticals, Janssen, Mediasphere, Medtelligence: Grant/Research Support (Ongoing); Medtronic, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Protembis, RenalPro, RM Global, Shockwave, Vivasure, Zoll: Grant/Research Support (Ongoing); Scientific Advisory Board for AMA, ACC (BOT Member, SC Member CTR Program), SCAI (Women in Innovations Committee Member), JAMA Cardiology Associate Editor; Faculty CRF: Scientific Advisory Board (Ongoing)

• Women Leaders in Interventional Cardiology

  Sunday, February 26, 2023
  1:10 PM – 1:30 PM ET

  Disclosure(s): Abbot, abiomed, alleviant medical, amgen, am-pharma, arena, AstraZeneca, Atricure: Grant/Research Support (Ongoing); Applied Therapeutics, Elixir Medical, Stel, ControlRad (spouse): Stock-privately held company (Ongoing); Bayer, Biosensors, Biotronik, Boston Scientific, Bristol-Myers Squibb, CardiaWave, CeloNova, Chiesi: Grant/Research Support (Ongoing); Cine-Med Research, Ionis Pharmaceuticals, Novartis, Novo Nordisk, Vectura, WebMD: Consultant (Ongoing); Concept Medical, CSL Behring, Cytosorbents, Daiichi Sankyo, Element Science, Faraday, Filterlex Medical, Humacyte, Idorsia Pharmaceuticals, Janssen, Mediasphere, Medtelligence: Grant/Research Support (Ongoing); Medtronic, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Protembis, RenalPro, RM Global, Shockwave, Vivasure, Zoll: Grant/Research Support (Ongoing); Scientific Advisory Board for AMA, ACC (BOT Member, SC Member CTR Program), SCAI (Women in Innovations Committee Member), JAMA Cardiology Associate Editor; Faculty CRF: Scientific Advisory Board (Ongoing)

• Panel Discussion: Optimal Duration of DAPT - How to Optimize Future Study Designs

  Sunday, February 26, 2023
  5:42 PM – 5:55 PM ET

  Disclosure(s): Abbot, abiomed, alleviant medical, amgen, am-pharma, arena, AstraZeneca, Atricure: Grant/Research Support (Ongoing); Applied Therapeutics, Elixir Medical, Stel, ControlRad (spouse): Stock-privately held company (Ongoing); Bayer, Biosensors, Biotronik, Boston Scientific, Bristol-Myers Squibb, CardiaWave, CeloNova, Chiesi: Grant/Research Support (Ongoing); Cine-Med Research, Ionis Pharmaceuticals, Novartis, Novo Nordisk, Vectura, WebMD: Consultant (Ongoing); Concept Medical, CSL Behring, Cytosorbents, Daiichi Sankyo, Element Science, Faraday, Filterlex Medical, Humacyte, Idorsia Pharmaceuticals, Janssen, Mediasphere, Medtelligence: Grant/Research Support (Ongoing); Medtronic, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Protembis, RenalPro, RM Global, Shockwave, Vivasure, Zoll: Grant/Research Support (Ongoing); Scientific Advisory Board for AMA, ACC (BOT Member, SC Member CTR Program), SCAI (Women in Innovations Committee Member), JAMA Cardiology Associate Editor; Faculty CRF: Scientific Advisory Board (Ongoing)